Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol : Jaein R&P

Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol

관리자

논문 게시판

BMJ journals / August 2018

Single-arm, open-label, dose-escalation phase I study to

evaluate the safety of a herbal medicine SH003 in

patients with solid cancer: a study protocol

Link;

https://bmjopen.bmj.com/content/8/8/e019502.long

A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer SH003‑induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells

목록

Single-arm, open-label, dose-escalation phase I study to

evaluate the safety of a herbal medicine SH003 in

patients with solid cancer: a study protocol

(주)재인알앤피